APA (7th ed.) Citation

AH, K., ERS, C., CA, J., GA, A., SW, D., EM, K., . . . C, C. (2023). Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis. Annals of internal medicine, 176(12), 1625. https://doi.org/10.7326/M22-2276

Chicago Style (17th ed.) Citation

AH, Kelkar, et al. "Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis." Annals of Internal Medicine 176, no. 12 (2023): 1625. https://doi.org/10.7326/M22-2276.

MLA (9th ed.) Citation

AH, Kelkar, et al. "Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis." Annals of Internal Medicine, vol. 176, no. 12, 2023, p. 1625, https://doi.org/10.7326/M22-2276.